Masimo landed the European CE mark of approval for its new MightySat Rx pulse oximeter to be used in clinical environments. The device, which is available in three versions, features Masimo’s SET Measure-Through Motion and Low Perfusion technology that’s part of the company’s clinical oximeters already common in hospitals worldwide.
Using a tablet or smartphone clinicians can tap the data gathered by the Bluetooth-enabled MightySat Rx devices, displaying readings such as SpO2, pulse rate, and perfusion index obtained over a twelve hour period. The MightySat Rx, Bluetooth and PVI version of the device also provides Pleth Variability Index (PVI), an indication of the changes in the perfusion index that occurs during respiratory cycles.
Additional features of the MightySat Rx according to the announcement:
Signal I.Q.® to assess measurement confidence
Rugged, lightweight design for operation in challenging environments
Long battery life–up to 15 hours with two standard AAA alkaline batteries
Comfortable design with silicon finger pad to mold to patients’ fingers